Fig. 4.
Subset analysis at 2, 5, 10, and 20 weeks posttransplant (CD2, CD4, CD8, CD16/56, and CD20) in high-dose animals.
T lymphocytes expressing CD2, CD4, CD8, and/or CD16/56, and B-lymphocytes expressing CD20 were evaluated by flow cytometry for coexpression of EGFP. Data are the mean percentage ± SEM (standard error of the mean) of these T and B lymphocytes expressing EGFP.